Published Date: 26 Apr 2023
By using interpretation and translation to present information to communities in their native language, public health outreach initiatives frequently aim to break down communication barriers. However, bilingual people from various cultural backgrounds.
Read Full NewsLack of access to innovative and effective treatments compromises survival outcomes for many patients in Europe with multiple myeloma.
A large study links the use of e-cigarettes after smoking cessation to higher lung cancer incidence and mortality than complete nicotine abstinence.
Post hoc analysis of the MajesTEC-3 trial shows the efficacy of the teclistamab plus daratumumab combination in hard-to-treat patients with high cytogenetic and functional risk.
Guidelines on treating cancer fatigue offer little enthusiasm for methylphenidate and other stimulants. But a recent meta-analysis suggests the medications deserve a rethink.
1.
Study: Pre-operative THP leads to pCR in 64% of early-stage HER2+ ER- breast cancer patients
2.
Hematocrit Stabilized in Polycythemia Vera Under Novel Hepcidin Mimetic Treatment.
3.
Global warming could be driving up women's cancer risk, find researchers
4.
In KRAS-mutated non-small cell lung cancer, glecirasib exhibits promising efficacy.
5.
CAR Natural Killer Cell Therapy Shows Promise in B-Cell Lymphomas
1.
Strategic Directions in Oncology in the Digital Era
2.
Personalized Cancer Vaccines: The Next Frontier in Precision Oncology
3.
Leptomeningeal Carcinomatosis: Symptoms, Causes, and Treatment Options
4.
Understanding Axitinib: What You Need To Know For Your Treatment Plan
5.
Refining AML Survival: Prognostic Factors, Therapies, and Stem Cell Strategies Reviewed
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII
2.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
3.
Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II
4.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
5.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation